July 06, 2017
George Allen, Pharm.D., associate professor and chair of the Department of Pharmacy Practice, and Kayla Harris (COP, ’18), have been published in the July 2017 issue of Antimicrobial Agents and Chemotherapy.
Allen and Harris’ manuscript describes their research evaluating the activity of a number of antimicrobials against the bacterium Shigella flexneri. This microorganism causes millions of infections worldwide each year, and the treatment of such infections is complicated by the high risk of antimicrobial resistance. The Centers for Disease Control and Prevention has designated Shigella as a serious antibiotic resistance threat, one of only twelve microorganisms named to this priority category.
Antimicrobial Agents and Chemotherapy is a monthly publication of the American Society for Microbiology, the largest life science professional organization in the world. The journal features interdisciplinary studies that build our understanding of myriad aspects of antimicrobial agents and therapy, including chemistry, pharmacology, mechanisms of action and resistance, experimental therapeutics and clinical applications. It is a key resource for professionals in the fields of microbiology and infectious diseases, including microbiologists, pharmaceutical researchers, biochemists, pharmacologists and clinicians.
To learn more about the University of New England’s College of Pharmacy, visit www.une.edu/pharmacy
To apply, visit www.une.edu/admissions